Cagrilintide ― 5mg

Tesamorelin  (C₂₂₁H₃₄₂N₆₂O₆₇) is a chemically modified synthetic analog of growth hormone–releasing hormone (GHRH 1–44) that incorporates a trans-3-hexenoic acid substitution to improve molecular stability. In experimental models, it interacts with GHRH receptors and is used to study mechanisms related to growth hormone production and release. As a research compound, tesamorelin is commonly applied in investigations of peptide–receptor interactions, kinetic stability, and regulation of the somatotropic axis within endocrine and metabolic systems.

AOD-9604 is a peptides fragment originates from residues 177–191 of the human growth hormone sequence and is examined in research for metabolic pathway activity that does not involve IGF-1 signaling. Laboratory studies indicate its effects are associated with regulation of lipid and glucose metabolism, with mechanistic links to β-adrenergic pathways and AMPK-related signaling. It is therefore used as an experimental tool in studies of cellular energy balance, adipocyte development, and metabolic pathway regulation.

Both are supplied in individual 3 mL vial as a lyophilized (freeze-dried) powder requiring reconstitution with a laboratory diluent. For laboratory research use only. Not for human or veterinary consumption.